Extending the post-thaw shelf-life of cryoprecipitate when stored at refrigerated temperatures

Vox Sang. 2024 Dec;119(12):1257-1267. doi: 10.1111/vox.13736. Epub 2024 Sep 18.

Abstract

Background and objectives: The post-thaw shelf-life of cryoprecipitate is 6 h, leading to high wastage. Storage of thawed cryoprecipitate at refrigerated temperatures may be feasible to extend the shelf-life. This study aimed to evaluate the quality of thawed cryoprecipitate stored at 1-6°C for up to 14 days.

Materials and methods: Cryoprecipitate (mini- and full-size packs derived from both apheresis and whole blood [WB] collections) was thawed, immediately sampled and then stored at 1-6°C for up to 14 days. Mini-packs were sampled at 6, 24, 48 and 72 h, day 7 and 14; full-size cryoprecipitate was sampled on day 3, 5 or 7. Coagulation factors (F) II, V, VIII, IX, X and XIII, von Willebrand factor (VWF) and fibrinogen were measured using a coagulation analyser. Thrombin generation was measured by calibrated automated thrombogram.

Results: FVIII decreased during post-thaw storage; this was significant after 24 h for WB (p = 0.0002) and apheresis (p < 0.0001). All apheresis and eight of 20 WB cryoprecipitate met the FVIII specification (≥ 70 IU/unit) on day 14 post-thaw. Fibrinogen remained stable for 48 h, and components met the specification on day 14 post-thaw. There were no significant differences in VWF (WB p = 0.1292; apheresis p = 0.1507) throughout storage. There were small but significant decreases in thrombin generation lag time, endogenous thrombin potential and time to peak for both WB and apheresis cryoprecipitate.

Conclusion: Whilst coagulation factors in cryoprecipitate decreased after post-thaw storage, the thawed cryoprecipitate met the Council of Europe specifications when stored at refrigerated temperatures for 7 days.

Keywords: coagulation factors; cryoprecipitate; fibrinogen; re‐precipitation; von Willebrand factor.

MeSH terms

  • Blood Coagulation Factors
  • Blood Preservation* / methods
  • Cryopreservation / methods
  • Factor VIII*
  • Fibrinogen*
  • Humans
  • Refrigeration
  • Time Factors

Substances

  • Fibrinogen
  • Factor VIII
  • cryoprecipitate coagulum
  • Blood Coagulation Factors

Grants and funding